Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Enters Offshore Arena with Global Energy Major

11 Oct 2010 07:00

RNS Number : 1413U
ViaLogy PLC
11 October 2010
 



 

ViaLogy Plc ("ViaLogy")

ViaLogy Enters Offshore Arena with Global Energy Major

Aims to demonstrate major improvements over conventional seismic analysis in deepwater and onshore

London, October 11, 2010. ViaLogy PLC (VIY) announces it has been engaged by a second global energy company for QuantumRD performance assessment projects. The analysis targets large oilfields outside the United States. Following the recent announcement of a supermajor contract, ViaLogy has been approached by several US and non-US companies for de-risking both onshore and offshore prospects.

Under the performance assessments, ViaLogy will use its proprietary quantum seismic interferometry technology, QuantumRD, to delineate productive formations in a deepwater reservoir for a large offshore development prospect. De-risking such prospects typically relies on drilling multiple, costly test wells because of the inability of conventional 3-D seismic analysis to image fluids. The offshore project requires that ViaLogy predict oil and/or gas bearing zones from 3D seismic data in a complex sandstone reservoir setting. Sandstone reservoirs are common across the globe and can be highly productive, depending upon the accuracy of mapping interlaced sediment within reservoir or basin-scale geometry to delineate source, seal and reservoir geologies. The value-add of QuantumRD is its ability to increase resolution of the seismic data to assess hydrocarbon presence and fluid saturation. The business value of being able to map subsurface saturation patterns is the potential to maximize extraction and production, and to avoid costs normally associated with locating hydrocarbons.

The client commissioning the work is a Fortune Global 500 company.

QuantumRD will also be used to determine the attributes of a major onshore formation for the client. The onshore application leverages QuantumRD's demonstrated ability to discover subtle channel sands in complex stratigraphies. ViaLogy intends to delineate and size production grade hydrocarbon-bearing depositions in an onshore reservoir that spans several hundred square miles.

These prospects have been previously analyzed by the some of the leading geophysical services providers. Both the client and the locations of the projects remain confidential.

ViaLogy has positioned QuantumRD to provide services on a global basis for a broad class of sandstone, carbonate and shale gas reservoirs to characterize formation porosity, lithology and map hydrocarbon presence. This follows two years of development and testing in onshore US prospects where QuantumRD successfully positioned multiple wells and, retrospectively, correctly explained the outcome of over 250 more wells.

ViaLogy CEO Robert W. Dean said, "These technology assessment projects are a major step forward for us, providing the opportunity to work in very large fields, showing the technology's capability offshore, and demonstrating its enormous commercial potential. In both of these offshore and onshore prospects currently available conventional seismic analysis technologies have thus far been unsuccessful."

 

For further information contact: 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy / Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner / Jeremy Stephenson, Corporate Broking +44 (0) 20-7107-8000

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMMMGDGFGGZM
Date   Source Headline
5th Nov 20207:00 amRNSDirectorate Change
3rd Nov 20207:00 amRNSPartnership with Take2 Health Limited
26th Oct 20207:00 amRNSHalf-year Trading update
23rd Oct 20207:00 amRNSCQC accreditation
21st Oct 20207:00 amRNSYourgene Genomic Services collaboration with Cytox
12th Oct 20207:00 amRNSElucigene DPYD tests to be used routinely in Wales
8th Oct 20207:00 amRNSStrategic reproductive health partnership in Japan
7th Oct 20207:00 amRNSIONA®Nx awarded contract with St George’s Hospital
5th Oct 20207:00 amRNSShare Incentive Plan
1st Oct 20204:59 pmRNSCorrection: Holding(s) in Company
1st Oct 20203:29 pmRNSHolding(s) in Company
28th Sep 20207:00 amRNSLaunch of Yourgene Genomic Services
25th Sep 20205:28 pmRNSIssue of Share Options
24th Sep 202010:00 amRNSDPD reimbursement in Germany
24th Sep 20207:00 amRNSDirector/PDMR Shareholding
23rd Sep 20205:20 pmRNSExercise of Options
23rd Sep 202012:25 pmRNSDirector/PDMR Shareholding
22nd Sep 20205:14 pmRNSResult of AGM
22nd Sep 20207:00 amRNSAGM Statement
21st Sep 20207:00 amRNSUS distribution agreement for DPYD &other products
9th Sep 20207:00 amRNSAGM update and investor presentation
3rd Sep 20207:00 amRNSIONA® Nx Launch
28th Aug 20207:00 amRNSNotice of AGM & Annual Report 2020
13th Aug 20207:00 amRNSTGA approves IONA® Nx for sale in Australia
11th Aug 20207:00 amRNSAdmission of Company Considerations Shares and TVR
7th Aug 20203:42 pmRNSHolding(s) in Company
7th Aug 20203:25 pmRNSHolding(s) in Company
7th Aug 20209:48 amRNSHolding(s) in Company
5th Aug 20201:15 pmRNSResult of Placing
5th Aug 20207:00 amRNS£16.15m Placing & Close of Accelerated Bookbuild
4th Aug 20205:13 pmRNSProposed Acquisition and Placing
3rd Aug 20207:00 amRNSCE-IVD Mark for Clarigene™ SARS-CoV-2 test
29th Jul 202012:05 pmRNSAppointment of Joint Broker
28th Jul 20207:00 amRNSFinal Results
13th Jul 20201:13 pmRNSNotice of Results
30th Jun 20207:00 amRNSCOVID-19 assay launched
19th Jun 20204:44 pmRNSIssue of Share Options
16th Jun 20207:00 amRNSCollaboration in COVID-19 testing
15th Jun 20207:00 amRNSCE-IVD mark received for Illumina-based IONA® test
26th May 202012:00 pmRNSHolding(s) in Company
26th May 20207:00 amRNSCOVID-19 testing service launch; business update
20th May 20207:00 amRNSExercise of Warrants and Options
20th Apr 20207:00 amRNSYear-end Trading update: Revenues increase 86%
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20204:41 pmRNSSecond Price Monitoring Extn
14th Apr 20204:36 pmRNSPrice Monitoring Extension
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSPresentation on ‘Adapting during crisis’

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.